BRCA1 and Duchenne muscular dystrophy: After the report of Kesari et al. [9], who were able to detect skipping events on cDNA from the Duchenne muscular dystrophy (DMD) gene using the respective genomic multiplex ligation probe amplification (MLPA) kit, we sought to evaluate the use of a commercially available BRCA1 MLPA kit [10] for the detection of exon skipping in cDNA instead of genomic DNA.